
Lorton, VA (February 3, 2026) — The U.S. Food and Drug Administration (FDA) has announced that Akkarco LLC is voluntarily recalling its Ashfiat Alharamain Energy Support Honey Product after laboratory testing found it contains undeclared tadalafil, a prescription-only drug used to treat erectile dysfunction. The FDA said products containing tadalafil cannot be marketed as dietary supplements, making the item an unapproved new drug with potential health risks.
After laboratory testing confirmed the presence of the drug, the agency notified the company and initiated the recall. In its safety notice, the FDA warned that consumers with underlying medical conditions or those taking certain medications could face serious side effects if they use the product.
Ashfiat Alharamain recall: quick summary
Akkarco LLC has recalled its honey-based energy support product nationwide after FDA testing found hidden tadalafil, a prescription medication not listed on the label. The company sold the product online through major e-commerce platforms. Although no confirmed illnesses have been reported, the FDA urges consumers to stop using the product immediately. This recall highlights ongoing concerns about undeclared pharmaceutical ingredients in supplements marketed for energy or sexual enhancement.
Official recall details
✦
Recall date: January 28, 2026 (FDA published February 3, 2026)
✦
Agency: U.S. Food and Drug Administration (FDA)
✦
Company: Akkarco LLC
✦
Brand: Ashfiat Alharamain
✦
Product: Honey Product for Energy Support
✦
Issue: Contains undeclared tadalafil (PDE5 inhibitor)
✦
Package details: Glass bottle with orange label
✦
UPC: 1234561870003
✦
Batch: ENCOT24
✦
Expiration: October 2028
✦
Consumer action: Stop using the product and follow return or disposal instructions from the seller
✦
Contact: United Legal Experts, [email protected], Mon–Fri 8 a.m.–4 p.m. EST
✦
Want to know more about what happened? Keep reading.
What happened?
The FDA said Akkarco LLC initiated the recall after discovering that its Ashfiat Alharamain Energy Support product contained tadalafil, a prescription-only substance approved for use only under medical supervision. Akkarco LLC announced the recall on January 28, 2026, in coordination with the FDA.
In its recall alert, the FDA warned that “products containing tadalafil cannot be marketed as dietary supplements” and said that “individuals with underlying medical conditions or who take certain medications face an increased risk of serious adverse events.”
The company packages the product in a glass bottle with an orange label and marks it with batch number ENCOT24 and an expiration date of October 2028. Akkarco LLC distributed the product nationwide through online retailers, including Amazon.
Affected products
Brand | Product | UPC | Best by date | Issue | Affected states |
|---|---|---|---|---|---|
Ashfiat Alharamain | Energy Support Honey Product | 1234561870003 | Oct 2028 | Undeclared tadalafil | Nationwide (U.S.) |
What caused the issue?
According to the FDA notice, laboratory analysis detected tadalafil, a phosphodiesterase (PDE5) inhibitor that can interact dangerously with nitrates and certain blood pressure medications. The FDA confirmed that no adverse health events have been reported so far.
Health risks include cardiovascular complications, changes in blood pressure, dizziness, and headaches. People with heart disease, diabetes, or those taking prescription medications are most at risk.
Questions you might have
Akkarco LLC is recalling Ashfiat Alharamain Honey Energy Support.
Laboratory testing found that the product contains undeclared tadalafil, a prescription-only drug.
Tadalafil treats erectile dysfunction and can cause serious side effects without medical supervision.
People with heart conditions, those taking nitrates or blood pressure medication, and older adults.
No confirmed adverse health events have been reported so far.
Check for UPC 1234561870003, batch ENCOT24, and expiration date October 2028.
It was distributed nationwide through online retailers, including major e-commerce platforms.
Stop using it immediately and follow the return or disposal instructions from the seller.
Dizziness, headache, chest pain, or changes in blood pressure.
Consumers can email United Legal Experts at [email protected] during business hours.
Here’s what you should do

- Stop using the product immediately.
- Check the label for UPC 1234561870003, batch ENCOT24, and expiration October 2028.
- Return or safely dispose of the product following the seller’s instructions.
- Contact Akkarco LLC at [email protected] for questions or refunds.
Behind the brand
Akkarco LLC, based in Lorton, Virginia, markets specialty wellness products under the Ashfiat Alharamain name. In its recall notice, the company stated that it is “working closely with its partners and platforms to ensure that all affected products are removed from distribution and sale.”
Source86 reached out to Akkarco LLC for comment on how the undeclared ingredient entered the supply chain, but has not yet received a response.
Other relevant recalls
This recall follows several recent FDA actions involving supplements found to contain hidden prescription drugs. Source86 has previously reported on multiple recalls affecting dietary and specialty food products due to undeclared ingredients and other safety concerns. Other recent recalls tied to different safety hazards include Gerber’s recall of Arrowroot Biscuits due to plastic and paper contamination, IKM’s recall of metal cookware over potential lead exposure, Suzanna’s Kitchen’s recall of ready-to-eat grilled chicken fillets because of possible Listeria contamination, and Mountain West Food Group’s recall of ground beef over concerns of E. coli O26 contamination.
Update: Akkarco Issues Specific Lot Recall (February 2026) Following reports of hidden ingredients in “energy” supplements, Akkarco LLC has issued a voluntary recall for a specific batch of Ashfiat Alharamain Energy Support honey. FDA testing confirmed that Lot ENGOT24 contains undeclared tadalafil, posing a serious safety risk to consumers with heart conditions or those taking nitrates. For the full details on how to identify the affected orange-label bottles and instructions for returns, read our specific recall report: Akkarco Recalls Energy Honey Over Undeclared Tadalafil.
Together, these incidents underscore the wide range of risks (from chemical adulteration to physical and bacterial contamination) facing today’s food and consumer product supply chains.
Eran Mizrahi, CEO of Source86, said the recall underscores a larger issue:
“Food safety isn’t just about compliance; it’s about trust. Every recall reminds us how vital transparency and supplier accountability truly are.”
Ensuring safe eats
This recall reflects a broader pattern of enforcement against unapproved drugs in dietary supplements. For consumers, it’s a reminder to buy wellness products from reputable sources and to report unusual side effects.
At Source86, we help food and supplement brands manage ingredient sourcing, FSQA oversight, and private label production with transparency and precision so when recalls happen, supply chains can respond quickly and responsibly. Contact us.









